Adele Busico

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (16)

Rossella Loria

Istituto Regina Elena

ITALY

View details

Paola Suatoni

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Laura Bergamaschi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Luca Roz

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Giancarlo Pruneri

University of Milan

ITALY

View details

Luigi Rolli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Monica Rodolfo

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Giovanni Centonze

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Gian Paolo Dagrada

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Stefano Cavalieri

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Silvia Damian

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Falcioni Rita

ITALY

View details

GIORGIO VALLE

Full professor

University of Padova

ITALY

View details

Mirko Marabese

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

Fabio Bozzi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Andrea Anichini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adele Busico

Research Interests

Explore related searches

Contact this professor

Articles (11)

Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case

Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis

Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples

Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles

LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.

The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer.

LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial.

Improved prognostic prediction in never-smoker lung cancer patients by integration of a systemic inflammation marker with tumor immune contexture analysis

Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.

<i>SMO</i> mutations confer poor prognosis in malignant pleural mesothelioma.

Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups

Collaborators (16)

Rossella Loria

Paola Suatoni

Laura Bergamaschi

Luca Roz

Giancarlo Pruneri

Luigi Rolli

Monica Rodolfo

Giovanni Centonze

Gian Paolo Dagrada

Stefano Cavalieri

Silvia Damian

Falcioni Rita

GIORGIO VALLE

Mirko Marabese

Fabio Bozzi

Andrea Anichini

Make your next move.